Health & Fitness
Health and Fitness
Health and Fitness
Fri, February 10, 2012
Thu, February 9, 2012
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
February 09, 2012 09:00 ET
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
HONG KONG--(Marketwire - Feb 9, 2012) - Today, [ www.BollingerReport.com ] introduced featured coverage of Acorda Therapeutics Inc (
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Bollinger Report screened and selected Acorda Therapeutics Inc for its current position within the healthcare industry. Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system. A copy of this report featuring Acorda Therapeutics Inc (
Bollinger Report is featuring Abbott Laboratories for its changing role within the healthcare industry. Abbott Laboratories is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. To download researches and analysis on Abbott Laboratories (
About Bollinger Report
Bollinger Report has come to be known among its peers as a trusted source of information for both investors and technical traders. Our online content is continually updated, bringing fresh new researches and analyses to the investment community.
